N@N

Rick Bienkowski Reiterated (VERV) at Hold and Held Target at $22 on, Sep 13th, 2023

Rick Bienkowski of Cantor Fitzgerald, Reiterated "Verve Therapeutics, Inc." (VERV) at Hold and Held Target at $22 on, Sep 13th, 2023.

Rick has made no other calls on VERV in the last 4 months.

There are 4 other peers that have a rating on VERV. Out of the 4 peers that are also analyzing VERV, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Richard Law of "Credit Suisse" Reiterated at Hold and Held Target at $31 on, Friday, August 11th, 2023

These are the ratings of the 3 analyists that currently disagree with Rick

---

• Seamus Fernandez of "Guggenheim" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, August 15th, 2023
• Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $29 on, Friday, June 16th, 2023
• Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Tuesday, May 16th, 2023

Contributing Sources

---